Clinical Kidney Journal

Article	Citations
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres	130
Correction to: Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials	95
Use of eHealth and remote patient monitoring: a tool to support home dialysis patients, with an emphasis on peritoneal dialysis	84
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study	70
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case–control study	68
Prolonged normothermic perfusion: a promising approach to kidney transplantation	62
Interaction of general obesity and abdominal obesity with frailty in patients with chronic kidney disease: a nationally representative analysis	53
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations	52
Can exercise improve outcomes for frail haemodialysis patients?	47
Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort	47
Recent advances in pathogenetic concepts and disease modeling of IgA nephropathy	47
Causal relationships between immune cell phenotypes and primary glomerular diseases: genetic evidence from bidirectional Mendelian randomization study	46
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients	44
Correction to: Recognition of intraglomerular histological features with deep learning in protocol transplant biopsies and their association with kidney function and prognosis	42
Bilateral nephrectomy in autosomal dominant polycystic kidney disease patients before or after renal transplantation: data from a retrospective cohort study	42
Toward acid- and heparin-free dialysis: the regional anticoagulation approach	41
Risk factors for acute kidney injury and kidney relapse in patients with lupus podocytopathy	40
Biomarkers in clinical epidemiology studies	38
Meet and greet but avoid the heat: a reflection on the carbon footprint of congresses prompted by ERA2023	38
Risk factors for steroid-induced osteonecrosis of the femoral head in children with immune kidney disease	37
Informal caregiver burden in dialysis care and how it relates to patients’ health-related quality of life and symptoms	36
Ten tips on how to manage kidney health in migrants and refugees	36
Differentiating primary and secondary FSGS using non-invasive urine biomarkers	36
Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR	35
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey	34

More dissimilarities than affinities between DNAJB11-PKD and ADPKD	33
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus	33
Non-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET/CT imaging	33
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function	33
A puzzling renal Fanconi syndrome	32
But how green is it actually? Calculating the environmental footprint of Kidney care environmental optimisations within haemodialysis	32
Donor-derived membranous nephropathy	31
Machine learning models for predicting acute kidney injury: a systematic review and critical appraisal	31
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective	31
The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease	30
Robot-assisted kidney transplantation: an update	29
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic	29
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study	29
Cerebral blood flow following successful living kidney transplantation: the VINTAGE study	29
Successful treatment of calciphylaxis with vitamin K in a patient on haemodialysis	28
Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis	28
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study	28
Prolonged detection of SARS-CoV-2 RNA in chronic haemodialysis patients	28
The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease	27
Visit-to-visit variability in blood pressure and kidney disease progression in IgA nephropathy	27
Prevalence and outcomes of chronic liver disease in patients receiving dialysis: systematic review and meta-analysis	27
Glomerular endothelial injury following vaccination for SARS-CoV-2	27
Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease	27
Introduction to new CKJ section: In Context – in collaboration with YNP	26
Coordinating efforts to optimize next-generation kidney replacement therapies: the European Kidney Health Alliance Work Group ‘Breakthrough Innovation’	26
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients	26
Strategies to prevent SARS-CoV-2 transmission in hemodialysis centres across Europe—lessons for the future	26
Treatment of primary hyperoxaluria type 1	26
The role of low health literacy in shared treatment decision-making in patients with kidney failure	25
Renal function is highly associated with podiatric risk in diabetic patients	25
Should we enlarge the indication for kidney biopsy in patients with diabetes? The pro part	25
The integrated care model: facilitating initiation of or transition to home dialysis	25
Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study	24
Genetic and clinical characterization of familial renal glucosuria	24
Understanding and targeting senescence in kidney disease	24
Cardiometabolic protein expression levels and pathways associated with kidney function decline in older European adults with advanced kidney disease	24
Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19	24
Efficacy and safety of belimumab in refractory and newly diagnosed active lupus nephritis patients: a real-world observational study	23
Addressing cognitive impairment in peritoneal dialysis: a systematic review and meta-analysis of prevalence, risk factors, and outcomes	23
Epidemiological risk factors for acute kidney injury outcomes in hospitalized adult patients: a multicenter cohort study	23
CD44-negative parietal–epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome	23
Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetes	23
Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease	23
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT Registry	23
Kidney Donor Profile Index and allograft outcomes: interactive effects of estimated post-transplant survival score and ischaemic time	23
Lower serum magnesium levels are associated with a higher risk of fractures and vascular calcifications in hemodialysis patients	22
Cerebral white matter injury in haemodialysis patients: a cross-sectional tract-based spatial statistics and fixel-based analysis	22
Glycemic control and complications in hemodialysis patients: the TURK-HEMODIAB STUDY	22
Multiomic profiling of new-onset kidney function decline: insights from the STANISLAS study cohort with a 20-year follow-up	22
Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney disease	22

Fibrillary glomerulonephritis: an observational study of clinical-pathological features and outcomes in patients from a multi-institutional cohort	22
Self-limited, sodium-dependent osmotic diuresis causes polyuria after living donor kidney transplantation	22
Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients	22
The burden of hyperkalaemia in chronic kidney disease: a systematic literature review	22
Association between beta-blocker utilization and heart failure mortality in the peritoneal dialysis population: a cohort study	22
Complications on the feeding artery after an arterio-venous fistula closure in patients after kidney transplantation – a national cohort study	21
Treatment of acute kidney injury in cancer patients	21
Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?	21
Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trials	21
Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis	21
The effect of sevelamer on serum calcification propensity in patients with chronic kidney disease: the results of a multicentre, double-blind, placebo-controlled, randomized clinical trial	21
Wasp stings and plasma exchange	21
International validation of a pre-transplant risk assessment tool for graft survival in pediatric kidney transplant recipients	21
How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies	20
Genetic testing in focal segmental glomerulosclerosis: in whom and when?	20
Humoral responses to BNT162b2 SARS-CoV-2 and hepatitis B vaccines are associated in patients on maintenance hemodialysis: a single-centre experience in Belgium	20
Association of renin–angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study	20
The Many Faces of NELL1 MN	20
Precision medicine for the treatment of glomerulonephritis: a bold goal but not yet a transformative achievement	20
Valvular heart disease in patients on kidney replacement therapy: “opening Pandora's box”	20
The assessment of hypertension in kidney transplant patients: time to change our approach?	20
Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications	20
Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies	20
Incidence of anti-glomerular basement membrane disease during the COVID-19 pandemic	20
Sugar-sweetened beverage consumption and mortality of chronic kidney disease: results from the US National Health and Nutrition Examination Survey, 1999–2014	19
Novel NUP160 mutations related to simultaneous congenital nephropathy and ovarian insufficiency	19
Partnering with patients and caregivers to enrich research and care in kidney disease: values and strategies	19
Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy	19
Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy	19
Remote management of anaemia in patients with end-stage kidney disease using a wearable, non-invasive sensor	19
Chronic prescription of antidepressant medication in patients with chronic kidney disease with and without kidney replacement therapy compared with matched controls in the Dutch general population	18
Designing qualitative research with value in the clinical and epidemiological context: what, why and how	18
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis	18
A 20-year follow-up study of identical twin sisters with immunoglobulin A nephropathy	18
Prevalence, awareness, treatment, and control of hypertension in community-dwelling older adults with chronic kidney disease: the Irish longitudinal study on ageing	18
Early and late acute kidney injury: temporal profile in the critically ill pediatric patient	18
Probiotics for kidney disease	18
Induction therapy for class I/II lupus nephritis with glucocorticoid monotherapy associates with higher relapse and poorer kidney outcomes	18
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseases	18
Association of deprivation and its individual domains on outcomes in people with chronic kidney disease	18
Fatigue across different chronic kidney disease populations: experiences and needs of patients	18
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association	18
Renal outcomes in immunoglobulin A nephropathy following COVID-19 vaccination: a retrospective cohort study	18
Estimating 24-hour urine phosphate excretion from spot urine	18
Integrating multiple kidney function markers to predict all-cause and cardiovascular disease mortality: prospective analysis of 366 758 UK Biobank participants	18
Personalizing electrolytes in the dialysis prescription: what, why and how?	18
RNA therapeutics in kidney diseases: prospects and current status	18
From electronic health records to clinical management systems: how the digital transformation can support healthcare services	18
Development and internal validation of a Wasp Sting Severity Score to assess severity and indicate blood purification in persons with Asian wasp stings	17
Predicting Prognosis in ANCA-Associated Vasculitis with Kidney Involvement	17
Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease	17
Potassium management and heart failure: a nephrologist's perspective	16
Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-up	16
Machine learning models for mortality prediction in critically ill patients with acute pancreatitis–associated acute kidney injury	16
Novel equations for estimating intraperitoneal pressure among peritoneal dialysis patients	16
Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial	16
Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease	16
Anticoagulation in patients with end-stage kidney disease and atrial fibrillation: a national population-based study	16
Automating kidney transplant rejection diagnosis: a simple solution for a complex problem?	16
Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation	16
Decoy receptors as biomarkers for exploring aetiology and designing new therapies	16
National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study	16
New aspects in cardiorenal syndrome and HFpEF	15
Differences in association between hypoalbuminaemia and mortality among younger versus older patients on haemodialysis	15
The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment	15
Collagen type III formation but not degradation is associated with risk of kidney disease progression and mortality after acute kidney injury	15
Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response	15
Anti-phospholipid antibodies nephropathy is associated with an increased risk of kidney failure: a systematic literature review and meta-analysis	15
Telitacicept Versus Mycophenolate Mofetil in IgA Nephropathy: A Real-World Comparative Study of Efficacy, Renal Outcomes, and Safety	15
Rituximab as a first-line therapy in children with new-onset idiopathic nephrotic syndrome	15
Correction to: Clinical implications of mineralocorticoid receptor overactivation	15
Dynamic prediction of kidney allograft and patient survival using post-transplant estimated glomerular filtration rate trajectory	15
Ageing meets kidney disease	15
Integrative analysis of the association between circadian rhythm and lupus nephritis	15
The role of blood purification therapies in the treatment of chronic kidney disease–associated pruritus: a systematic review	15
Liver safety of tolvaptan in patients with autosomal dominant polycystic kidney disease: interim data from a post-authorization safety study	15
Long-term effect of increasing water intake on repeated self-assessed health-related quality of life (HRQoL) in autosomal dominant polycystic kidney disease	15
Multiparametric MRI: can we assess renal function differently?	15
Management of hypertension in patients with cancer: challenges and considerations	15
Renal involvement is frequent in adults with primary mitochondrial disorders: an observational study	15

The Latin American Dialysis and Renal Transplantation Registry: report 2019	14
Urinary soluble PD-1 as a biomarker of checkpoint inhibitor-induced acute tubulointerstitial nephritis	14
Three decades of CKD due to diabetes mellitus type 2 in China, with projections of disease burden from 2022 to 2036: a systematic analysis for the Global Burden of Disease Study 2021	14
COVID-19 among kidney transplant recipients: evaluating risk factors during the initial phase of the pandemic	14
Current practices in prevention, screening, and treatment of diabetes in kidney transplant recipients: European survey highlights from the ERA DESCARTES Working Group	14
Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003–21	14
Prospective evaluation of CAR-T cell therapy-related proteinuria and kidney dysfunction	14
Reply to ‘Depression and clinical outcomes in CKD: do anti-depressants play a role? (EQUAL Study)’	14
Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors	14
Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care	14
New and old GFR equations: a European perspective	14
Defining diagnostic trajectories in patients with podocytopathies	14
Association of albuminuria with incident atrial fibrillation in healthy older adults	13
Hyponatremia and the risk of sepsis in the setting of chronic kidney disease not on dialysis	13
Immobilization-associated hypercalcaemia in patients with malignancy in the hospital setting	13
Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor–associated membranous nephropathy	13
Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices	13
Cardiovascular risk prediction in hemodialysis patients using the triglyceride-glucose index: a multicenter prospective cohort study	13
Prospective study of the effect of rituximab on kidney function in membranous nephropathy	13
Correction to: Moving on obesity treatment in CKD: inertia is unjustified	13
Mechanisms and treatment of obesity-related hypertension—Part 2: Treatments	13
Prophylactic proton pump inhibitor usage and new-onset acute kidney injury in critically ill patients: a retrospective analysis	13
Incremental versus conventional haemodialysis in end-stage kidney disease: a systematic review and meta-analysis	13
Association between serum short-chain fatty acid levels and the risk of all-cause and cardiovascular disease mortality in Chinese patients undergoing maintenance hemodialysis: a retrospective cohort s	13
Mortality associated with the COVID-19 pandemic in the Swiss dialysis population beyond SARS-CoV-2 infection	13
Asymmetric dimethylarginine and citrulline are risk factors for cardiovascular disease independently of both estimated and measured GFR	13
Anti-nephrin antibody: a potential biomarker of minimal change disease	13
Malignancies and glomerulonephritis: when to suspect and when to screen?	13
Risk factors for major bleeding in patients with atrial fibrillation and CKD G3–G5D on oral anticoagulants	13
Performance of an interstitial glucose monitoring device in patients with type 1 diabetes during haemodialysis	13
Considering the utility of urinary amino acids for early identification of non-diabetic chronic kidney disease	12
Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease	12
Synergistic effect of teclistamab with PD-1 inhibition: a case of acute interstitial nephritis with dual immunotherapy	12
Time-averaged concentration estimation of uraemic toxins with different removal kinetics: a novel approach based on intradialytic spent dialysate measurements	12
Cystatin C–based estimated GFR performs best in identifying individuals with poorer survival in an unselected Chinese population: results from the China Health and Retirement Longitudinal Study (CHARL	12
Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?	12
Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease	12
Urinary microvesicles: a window into the kidney	12
Nafamostat mesylate has advantages as an anticoagulant for patients undergoing maintenance hemodialysis with conjunctival bleeding	12
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab	12
Trunk muscle quality and quantity are associated with renal volume in nondiabetic people	12
Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort	12
A review of supportive care for older people with advanced chronic kidney disease	12
Patterns of chronic and transient hyperkalaemia and clinically important outcomes in patients with chronic kidney disease	12
Kidney–placenta crosstalk in health and disease	12
Personalized peritoneal dialysis prescription—beyond clinical or analytical values	12
The elevation of the anion gap in steady state chronic kidney disease may be less prominent than generally accepted	12
Social Deprivation as a Key Driver of Spatial Disparities in End-Stage Kidney Disease Incidence	12
The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients	12
Lung ultrasonography performed by nephrologist: COVID-19 as an opportunity to reveal ultrasound's full potential and usefulness in the dialysis room	11
Association of secondary prevention medication use after myocardial infarction with mortality in hemodialysis patients	11
Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes	11
Associations between iron markers with hemoglobin and outcomes in peritoneal dialysis patients: results from the PDTAP study	11
Outcomes of patients with COVID-19 on kidney replacement therapy: a comparison among modalities in England	11
Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms	11
Kidney replacement therapy patients with COVID-19 in the vaccine era: what do we need to know?	11
Hypoxia-inducible factor prolyl hydroxylase inhibitors in kidney transplant recipients	11
Reply to ‘Stability and compatibility of antibiotics in PD solutions—call for including antibiotics for drug-resistant infections’	11
Twenty-four-hour proteinuria levels are associated with adverse pregnancy outcomes among women with CKD	11
C5a receptor inhibitor avacopan in immunoglobulin A nephropathy—an open-label pilot study	11
A treasure from a barren island: the discovery of rapamycin	11
Chronic kidney disease duration and suicide risk among maintenance hemodialysis patients in China	11
Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis	11
Contemporary outcomes of anemia in US patients with chronic kidney disease	11
Matrix Gla protein polymorphism rs1800802 is associated with atheroma plaque progression and with cardiovascular events in a chronic kidney disease cohort	11
History of creatinine clearance: tribute to a forerunner	11
The long-term benefits of early intensive therapy in chronic diseases—the legacy effect	11
Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients	11
Incidence and prognosis of acute kidney injury versus acute kidney disease among 71 041 inpatients	11
An update on absolute and relative indications for dialysis treatment modalities	11
Disturbance in the potential cardiovascular–bone–skeletal muscle axis and morbidity and mortality in patients undergoing haemodialysis: the Q-Cohort Study	11
Bone mineral density after exercise training in patients with chronic kidney disease stages 3 to 5: a sub-study of RENEXC—a randomized controlled trial	11
Prophylactic ultra-low dose rituximab to maintain remission in relapsing adult minimal change disease	11
Trajectories of urea‑to‑creatinine ratio and risk of clinical outcomes in survivors of acute kidney disease: a population-based study	11
Cystatin C–based estimated glomerular filtration rate and risk of stroke in the general population: a prospective cohort study	11
The effect of standard percutaneous nephrolithotomy, miniaturized percutaneous nephrolithotomy and retrograde intrarenal surgery on biomarkers of renal injury: a randomized clinical trial	11
New trials in resistant hypertension: mixed blessing stories	11
The ERA Registry Annual Report 2019: summary and age comparisons	11
Longitudinal serum bicarbonate and mortality risk in older patients with advanced chronic kidney disease: analyses from the EQUAL cohort	11
ERA Registry Figure of the month Expected remaining years of life for dialysis and kidney transplant patients	10
Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney disease	10
The risk of CKD progression remains high in patients treated with ACE inhibitors and ARBs, MRAs and SGLT2 inhibitors. Have we already achieved the therapeutic ceiling in CKD? (The CON part)	10
A pre-transplantation risk assessment tool for graft survival in Dutch pediatric kidney recipients	10
Monoallelic pathogenic IFT140 variants are a common cause of autosomal dominant polycystic kidney disease–spectrum phenotype	10
Ten Tips to Teach Learners to Love Nephrology (and Recruit the Next Generation)	10
Activation of the inflammasome and pyroptosis cascade in podocytes of patients with minimal change disease	10
Kidney Failure Risk Equation performance according to the etiology of chronic kidney disease in the CKD-CAREMEAU Cohort	10
Circulating metabolites associated with kidney function decline and incident CKD: a multi-platform population-based study	10
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with onl	10
Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term	10
Correction to: Using artificial intelligence to predict mortality in AKI patients: a systematic review/meta-analysis	10
Efficacy and safety of finerenone in IgA nephropathy: an observational multicentre study	10
Association of urinary albumin:creatinine ratio with incident frailty in older populations	10
Gut-immune axis and cardiovascular risk in chronic kidney disease	10
The diagnostic accuracy of ultrasound and genomic tests for the diagnosis of autosomal-dominant polycystic kidney disease: a systematic mapping review	10